Advances in alliteration in acute myocardial infarction: From 'Time to treatment' to 'Onset to opening'

Journal of Thrombosis and Thrombolysis

Volumn 6, Issue 1, 1998, Pages 5-7

  Cannon, Christopher P ^a   Smith, Mark ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HUMAN; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

EID: 0031709886     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008818103943     Document Type: Article

References (20)

1. Simoons ML, Serruys PW, van den Brand M, et al. Improved survival after early thrombolysis in acute myocardial infarction. A randomized trial by the Interuniversity of Cardiology Institute in the Netherlands. Lancet 1985;2:578-681.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.
4. ASSET Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988;2:525-530.
5. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: Should the paradigm be expanded? Circulation 1989;79:441-444.
6. Grines CL, Weaver DW Treating myocardial infarction: Importance of early reperfusion. Lancet 1994;344:490-491.
7. Cannon CP, Antman EM, Walls R, Braunwald E. Time as an adjunctive agent to thrombolytic therapy. J Thromb Thrombolysis 1994;1:27-34.
8. Pell ACH, Miller HC, Robertson CE, Fox KAA. Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis. Br Med J 1992;304:83-7.
9. National Heart Attack Alert Program Coordinating Committee - 60 Minutes to Treatment Working Group. Emergency department: Rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994;23:311-329.
10. Lambrew CT. Emergency Department triage of patients with nontraumatic chest pain. ACC Curr J Rev 1995;4: 61-62.
11. Granger CB, Califf RM, Topol EJ. Thrombolytic therapy for acute myocardial infarction. Drugs 1992;44:293-325.
12. The GUSTO Angiographic Investigators. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-1622.
13. Cannon CP, McCabe CH, Diver DJ, et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol 1994;24:1602-1610.
14. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
15. Topol EJ, Califf RM, Lee KL, on behalf of the GUSTO Investigators. More on the GUSTO trial [letter]. N Engl J Med 1994;331:277-278. Published errata appear in N Engl J Med 1994;331:687, and 1994;331:1323.
16. Cannon CP, Braunwald E. Time to reperfusion: The critical modulator in thrombolysis and primary angioplasty. J Thromb Thrombolysis 1996;3:109-117.
17. Cannon CP, Lambrew CT, Tiefenbrunn AJ, et al. Influence of door-to-balloon time on Mortality in Primary Angioplasty Results in 3,648 patients in the Second National Registry of Myocardial Infarction (NRMI-2) (abstrt). J Am Coll Cardiol 1996;27(Suppl. A):61A-62A.
18. Caputo RP, Ho KK, Stoler RC, et al. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1997;79:1159-1164.
19. Patel S, Reese C, O'Connor RE, Doorey AJ. Adverse outcomes accompanying primary angioplasty (PTCA) for acute myocardial infarction (AMI) - dangers of delay (abstrt). J Am Coll Cardiol 1996;27(Suppl. A):62A.
20. Berger PB, Holmes DR, Califf RM, Criger DA. Hospital delay in achieving reperfusion with direct PTCA in GUSTO-IIb: Relationship to 30-day mortality. (Abstract) Circulation 1997;96(Supp. 1):I-531.